Spotify Technology S.A. Ordinary Shares (SPOT)
StalwartFairStock Score: 56/100 — STEADY
Key Financials
| Current Price | $436.94 |
| Market Cap | $104.1B |
| P/E Ratio | 29.21 |
| ROE | 37.99% |
| Dividend Yield | —% |
| Sector | Communication Services |
Strengths
- Generates $675 million in annual free cash flow (0.6% yield on market cap)
- Strong Piotroski F-Score of 8/9 indicating robust financial health across profitability, leverage, and efficiency metrics
- High return on equity of 31.9% demonstrating efficient capital deployment
- Conservative balance sheet with debt-to-equity of just 0.23, providing financial flexibility
- Altman Z-Score of 10.1 confirms minimal bankruptcy risk and strong solvency
Concerns
- Trades significantly above Graham Number ($106) with negative 377% margin of safety—limited downside protection
- No meaningful dividend despite modest growth—total return depends entirely on multiple expansion
AI Analysis
Spotify Technology S.A. Ordinary Shares is a large-cap communication services company valued at $104.1 billion. The business generates $17.2 billion in annual revenue with a 6.8% net margin and $675 million in free cash flow. From a quality standpoint, Spotify shows near-perfect Piotroski F-Score of 8/9 indicating exceptional financial health and Altman Z-Score of 10.1 confirms fortress-level solvency. On valuation, the stock is commanding a steep 41.8x multiple, with trades far above its Graham Number ($106) with no margin of safety. Growth dynamics show revenue growing at 6.8% and profit growth of 219.9%. Our composite FairStock Score of 59/100 reflects mixed fundamentals overall. The premium valuation demands continued execution and leaves limited room for disappointment.
Bull Case
Spotify's dominant market position and scale advantages create a durable moat that supports premium valuation over time. With $675 million in annual free cash flow (0.6% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
At 42x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer